Annual SG&A
$390.87 M
+$84.45 M+27.56%
31 December 2023
Summary:
NovoCure Limited annual selling, general & administrative expenses is currently $390.87 million, with the most recent change of +$84.45 million (+27.56%) on 31 December 2023. During the last 3 years, it has risen by +$165.41 million (+73.37%). NVCR annual SG&A is now at all-time high.NVCR Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$99.93 M
+$5.61 M+5.94%
30 September 2024
Summary:
NovoCure Limited quarterly selling, general & administrative expenses is currently $99.93 million, with the most recent change of +$5.61 million (+5.94%) on 30 September 2024. Over the past year, it has increased by +$82.00 thousand (+0.08%). NVCR quarterly SG&A is now at all-time high.NVCR Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$4.16 B
-$149.78 M-3.74%
30 September 2024
Summary:
NovoCure Limited TTM selling, general & administrative expenses is currently -$4.16 billion, with the most recent change of -$149.78 million (-3.74%) on 30 September 2024. Over the past year, it has dropped by -$4.54 billion (-1193.79%). NVCR TTM SG&A is now -1402.93% below its all-time high of $392.49 million, reached on 31 March 2024.NVCR TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NVCR Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +27.6% | +0.1% | -1193.8% |
| 3 y3 years | +73.4% | +56.6% | -1743.1% |
| 5 y5 years | +158.7% | +114.7% | -2483.6% |
NVCR Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +73.4% | at high | +56.6% | -61.8% | at low |
| 5 y | 5 years | at high | +158.7% | at high | +114.7% | -63.4% | at low |
| alltime | all time | at high | +1084.2% | at high | +859.3% | -1402.9% | at low |
NovoCure Limited Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $99.93 M(+5.9%) | $387.63 M(+0.0%) |
| June 2024 | - | $94.33 M(-0.4%) | $387.55 M(-1.3%) |
| Mar 2024 | - | $94.74 M(-4.0%) | $392.49 M(+0.4%) |
| Dec 2023 | $390.87 M(+27.6%) | $98.64 M(-1.2%) | $390.87 M(+2.9%) |
| Sept 2023 | - | $99.85 M(+0.6%) | $379.93 M(+7.3%) |
| June 2023 | - | $99.27 M(+6.6%) | $353.98 M(+6.9%) |
| Mar 2023 | - | $93.11 M(+6.2%) | $331.13 M(+8.1%) |
| Dec 2022 | $306.41 M(+16.4%) | $87.70 M(+18.7%) | $306.41 M(+6.1%) |
| Sept 2022 | - | $73.90 M(-3.3%) | $288.70 M(+3.6%) |
| June 2022 | - | $76.42 M(+11.7%) | $278.61 M(+3.5%) |
| Mar 2022 | - | $68.39 M(-2.3%) | $269.09 M(+2.2%) |
| Dec 2021 | $263.18 M(+16.7%) | $69.99 M(+9.7%) | $263.18 M(+4.1%) |
| Sept 2021 | - | $63.81 M(-4.6%) | $252.91 M(+3.0%) |
| June 2021 | - | $66.90 M(+7.1%) | $245.53 M(+5.6%) |
| Mar 2021 | - | $62.48 M(+4.6%) | $232.50 M(+3.1%) |
| Dec 2020 | $225.45 M(+22.1%) | $59.72 M(+5.8%) | $225.46 M(+4.2%) |
| Sept 2020 | - | $56.42 M(+4.8%) | $216.29 M(+4.8%) |
| June 2020 | - | $53.87 M(-2.8%) | $206.40 M(+4.5%) |
| Mar 2020 | - | $55.44 M(+9.7%) | $197.49 M(+7.0%) |
| Dec 2019 | $184.62 M | $50.55 M(+8.6%) | $184.62 M(+5.9%) |
| Sept 2019 | - | $46.54 M(+3.5%) | $174.34 M(+5.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2019 | - | $44.96 M(+5.6%) | $165.78 M(+4.8%) |
| Mar 2019 | - | $42.57 M(+5.7%) | $158.23 M(+4.7%) |
| Dec 2018 | $151.12 M(+23.2%) | $40.28 M(+6.0%) | $151.12 M(+5.4%) |
| Sept 2018 | - | $37.98 M(+1.5%) | $143.32 M(+4.7%) |
| June 2018 | - | $37.40 M(+5.5%) | $136.94 M(+4.6%) |
| Mar 2018 | - | $35.46 M(+9.2%) | $130.92 M(+6.8%) |
| Dec 2017 | $122.64 M(+11.0%) | $32.48 M(+2.8%) | $122.64 M(+3.2%) |
| Sept 2017 | - | $31.60 M(+0.7%) | $118.84 M(+2.6%) |
| June 2017 | - | $31.38 M(+15.5%) | $115.82 M(+3.3%) |
| Mar 2017 | - | $27.18 M(-5.2%) | $112.07 M(+1.5%) |
| Dec 2016 | $110.46 M(+51.9%) | $28.68 M(+0.3%) | $110.46 M(+2.6%) |
| Sept 2016 | - | $28.59 M(+3.5%) | $107.62 M(+11.7%) |
| June 2016 | - | $27.63 M(+8.1%) | $96.35 M(+13.4%) |
| Mar 2016 | - | $25.56 M(-1.1%) | $84.96 M(+16.8%) |
| Dec 2015 | $72.72 M(+60.8%) | $25.84 M(+49.2%) | $72.72 M(+21.5%) |
| Sept 2015 | - | $17.32 M(+6.7%) | $59.88 M(+13.0%) |
| June 2015 | - | $16.23 M(+21.8%) | $52.97 M(+44.2%) |
| Mar 2015 | - | $13.33 M(+2.6%) | $36.74 M(+56.9%) |
| Dec 2014 | $45.23 M(+37.0%) | $12.99 M(+24.7%) | $23.41 M(+124.7%) |
| Sept 2014 | - | $10.42 M | $10.42 M |
| Dec 2013 | $33.01 M | - | - |
FAQ
- What is NovoCure Limited annual selling, general & administrative expenses?
- What is the all time high annual SG&A for NovoCure Limited?
- What is NovoCure Limited annual SG&A year-on-year change?
- What is NovoCure Limited quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for NovoCure Limited?
- What is NovoCure Limited quarterly SG&A year-on-year change?
- What is NovoCure Limited TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for NovoCure Limited?
- What is NovoCure Limited TTM SG&A year-on-year change?
What is NovoCure Limited annual selling, general & administrative expenses?
The current annual SG&A of NVCR is $390.87 M
What is the all time high annual SG&A for NovoCure Limited?
NovoCure Limited all-time high annual selling, general & administrative expenses is $390.87 M
What is NovoCure Limited annual SG&A year-on-year change?
Over the past year, NVCR annual selling, general & administrative expenses has changed by +$84.45 M (+27.56%)
What is NovoCure Limited quarterly selling, general & administrative expenses?
The current quarterly SG&A of NVCR is $99.93 M
What is the all time high quarterly SG&A for NovoCure Limited?
NovoCure Limited all-time high quarterly selling, general & administrative expenses is $99.93 M
What is NovoCure Limited quarterly SG&A year-on-year change?
Over the past year, NVCR quarterly selling, general & administrative expenses has changed by +$82.00 K (+0.08%)
What is NovoCure Limited TTM selling, general & administrative expenses?
The current TTM SG&A of NVCR is -$4.16 B
What is the all time high TTM SG&A for NovoCure Limited?
NovoCure Limited all-time high TTM selling, general & administrative expenses is $392.49 M
What is NovoCure Limited TTM SG&A year-on-year change?
Over the past year, NVCR TTM selling, general & administrative expenses has changed by -$4.54 B (-1193.79%)